FOLDIKINE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

FOLDIKINE Trademark

Serial Number: 79366890 • Registration: 7334166

FOLDIKINE is a trademark filed by FUNDACIÓ CENTRE DE REGULACIÓ GENÒMICA on December 7, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

FUNDACIÓ CENTRE DE REGULACIÓ GENÒMICA (5 trademarks)

C. Doctor Aiguader, 88

Entity Type: 99

Trademark Details

Filing Date

December 7, 2022

Registration Date

March 26, 2024

Published for Opposition

January 9, 2024

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 21, 2024 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Nov 15, 2024 XXSS
GENERIC MADRID TRANSACTION CREATED
Nov 14, 2024 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 27, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 26, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 26, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 9, 2024 PUBO
NOTIFICATION PROCESSED BY IB
Jan 8, 2024 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 20, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 20, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 20, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 29, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 14, 2023 TROA
REFUSAL PROCESSED BY IB
Oct 25, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 3, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 3, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 21, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 20, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 13, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 14, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 10, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 6, 2023 REPR